G. M. Murphy

2.3k total citations
65 papers, 1.8k citations indexed

About

G. M. Murphy is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G. M. Murphy has authored 65 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 27 papers in Surgery and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G. M. Murphy's work include Drug Transport and Resistance Mechanisms (24 papers), Gallbladder and Bile Duct Disorders (16 papers) and Pediatric Hepatobiliary Diseases and Treatments (12 papers). G. M. Murphy is often cited by papers focused on Drug Transport and Resistance Mechanisms (24 papers), Gallbladder and Bile Duct Disorders (16 papers) and Pediatric Hepatobiliary Diseases and Treatments (12 papers). G. M. Murphy collaborates with scholars based in United Kingdom, Canada and United States. G. M. Murphy's co-authors include R. H. Dowling, Barbara H. Billing, D N Baron, E Signer, I. A. D. Bouchier, J. A. H. Wass, I Forgács, M. N. Maisey, R.H. Dowling and G. M. Besser and has published in prestigious journals such as The Lancet, Gastroenterology and Gut.

In The Last Decade

G. M. Murphy

63 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. M. Murphy United Kingdom	26	638	598	465	341	275	65	1.8k
Gershon W. Hepner United States	28	526 0.8×	590 1.0×	225 0.5×	542 1.6×	332 1.2×	65	2.4k
William H. Admirand United States	11	815 1.3×	681 1.1×	699 1.5×	262 0.8×	177 0.6×	13	1.7k
Hans Fromm United States	26	1.0k 1.6×	897 1.5×	664 1.4×	642 1.9×	341 1.2×	120	2.6k
T.C. Northfield United Kingdom	21	581 0.9×	348 0.6×	360 0.8×	269 0.8×	97 0.4×	50	1.2k
W.G.M. Hardison United States	24	471 0.7×	570 1.0×	107 0.2×	421 1.2×	271 1.0×	54	1.5k
C. N. Williams Canada	20	691 1.1×	426 0.7×	189 0.4×	846 2.5×	245 0.9×	55	2.0k
Anne Myara France	22	505 0.8×	530 0.9×	191 0.4×	204 0.6×	547 2.0×	53	1.6k
A. Stiehl Germany	28	1.1k 1.7×	782 1.3×	414 0.9×	809 2.4×	171 0.6×	103	2.2k
G.M. Murphy United Kingdom	20	374 0.6×	337 0.6×	295 0.6×	246 0.7×	144 0.5×	57	1.1k
Malcolm P. Tyor United States	20	328 0.5×	293 0.5×	210 0.5×	172 0.5×	143 0.5×	54	1.3k

Countries citing papers authored by G. M. Murphy

Since Specialization

Citations

This map shows the geographic impact of G. M. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. M. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. M. Murphy more than expected).

Fields of papers citing papers by G. M. Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. M. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. M. Murphy. The network helps show where G. M. Murphy may publish in the future.

Co-authorship network of co-authors of G. M. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of G. M. Murphy. A scholar is included among the top collaborators of G. M. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. M. Murphy. G. M. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Veysey, Martin, Ludivine Thomas, Anthony I. Mallet, et al.. (1999). Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones. Gut. 44(5). 675–681. 54 indexed citations

Chang, Esther H., Young‐Ju Jang, Hao Zhou, et al.. (1997). Restoration of the G1 Checkpoint and the Apoptotic Pathway Mediated by Wild-type p53 Sensitizes Squamous Cell Carcinoma of the Head and Neck to Radiotherapy. Archives of Otolaryngology - Head and Neck Surgery. 123(5). 507–512. 34 indexed citations

Thomas, Ludivine, Anna King, G.L. French, G. M. Murphy, & R. H. Dowling. (1997). Cholylglycine hydrolase and 7α-dehydroxylase. Clinica Chimica Acta. 268(1-2). 61–72. 14 indexed citations

Pereira, Stephen P., Martin Veysey, C Kennedy, et al.. (1996). Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones.. Gut. 38(5). 775–783. 63 indexed citations

Verdú, Elena F., Robert Fraser, G. M. Murphy, A. L. Blum, & David Armstrong. (1995). The Origin of Nocturnal Intragastric pH Rises in Healthy Subjects. Scandinavian Journal of Gastroenterology. 30(10). 935–943. 16 indexed citations

Ellul, Mark, et al.. (1994). British Association for the Study of the Liver. Gut. 35(5). A719–A722. 1 indexed citations

Rhodes, M, Adrian Allen, R. H. Dowling, G. M. Murphy, & T.W.J. Lennard. (1992). Inhibition of human gall bladder mucus synthesis in patients undergoing cholecystectomy.. Gut. 33(8). 1113–1117. 28 indexed citations

Hall, Peter A., N R Lemoine, G. M. Murphy, & R. H. Dowling. (1991). Molecular differences between human and experimental pancreaticobiliary diversion-induced rat pancreatic neoplasia.. Gut. 32(5). 533–535. 10 indexed citations

Taylor, P.R., Robert C. Mason, M I Filipe, et al.. (1991). Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: morphology, mucin histochemistry, polyamine metabolism, and labelling index.. Gut. 32(12). 1447–1454. 47 indexed citations

10.

Alison, Malcolm, et al.. (1991). Effect of α-difluoromethylornithine on the polyamine levels and proliferation in two transplantable tumours. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 419(3). 223–230. 3 indexed citations

11.

Rokkas, Theodore, S. Vaja, P.R. Taylor, G. M. Murphy, & R.H. Dowling. (1990). Is the Intestine the Sole Source of Heparin-Stimulated Plasma Diamine Oxidase?. Digestion. 46(2). 439–446. 12 indexed citations

12.

Taylor, Peter R., et al.. (1989). Induction of pancreatic tumours by longterm duodenogastric reflux.. Gut. 30(11). 1596–1600. 15 indexed citations

13.

Armstrong, David, Michael Farrell, A M Hanby, G. M. Murphy, & R. H. Dowling. (1988). Is the ex vivo rat gastric chamber model suitable for studying the gastrotoxicity of refluxed duodenal contents? Initial results using deoxycholic acid. Clinica Chimica Acta. 178(3). 313–325. 3 indexed citations

14.

Toseland, P. A., et al.. (1988). Tentative Identification of a Digoxin-like Immunoreactive Substance. Therapeutic Drug Monitoring. 10(2). 168–171. 9 indexed citations

15.

Hosomi, Masahiro, et al.. (1987). Role of polyamines in intestinal adaptation in the rat. European Journal of Clinical Investigation. 17(5). 375–385. 27 indexed citations

16.

Setchell, Kenneth D.R., et al.. (1982). Diurnal changes in serum unconjugated bile acids in normal man.. Gut. 23(8). 637–642. 70 indexed citations

17.

Leòn, Maurizio Ponz de, G. M. Murphy, & R. H. Dowling. (1978). Physiological factors influencing serum bile acid levels. Gut. 19(1). 32–39. 39 indexed citations

18.

Bell, G. D., et al.. (1978). Effect of ioglycamide (Biligram) on bile flow and biliary lipid secretion in man.. Gut. 19(4). 300–307. 15 indexed citations

19.

Iser, J. H., et al.. (1978). Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones. BMJ. 1(6126). 1509–1512. 48 indexed citations

20.

Murphy, G. M., et al.. (1972). Serum bile acids in primary biliary cirrhosis. Gut. 13(3). 201–206. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact